Crop Life Science Share Price Today

Crop Life Science promoters sell 4.8 lakh shares on NSE

Crop Life Science Limited disclosed that its promoters sold 4,80,000 equity shares on the NSE on July 02, 2026, for an aggregate value of ₹2.06 crore. The sale, conducted under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, reduced the promoters' total holding to 48.86% of the paid-up equity share capital.

Crop Life Science appoints Sheetalben Shah as Independent Director for 5 years

Crop Life Science Ltd has regularized the appointment of Ms. Sheetalben Rachit Shah as a Non-Executive Independent Director for a five-year term effective April 10, 2026, following approval through a postal ballot where 99.97% of votes were cast in favour. The resolution was supported by the promoter group and public shareholders, with the process overseen by scrutinizer Mr. Ranjit Kumar Singh. Ms. Shah brings expertise in management and corporate governance, and the company confirmed she is not debarred by SEBI from holding the position.

Crop Life Science reports FY26 net profit of ₹698.69 lakh

[Crop Life Science](https://scanx.trade/company/crop-life-science-ltd) reported a net profit of ₹698.69 lakh for the year ended March 31, 2026, up from ₹662.03 lakh in the previous year. Revenue from operations increased to ₹20,717.42 lakh from ₹20,059.00 lakh. The Board approved the audited financial results on May 26, 2026, and the statutory auditors issued an unmodified opinion.

Crop Life Science approves ₹7.96 crore loan from HDFC Bank

Crop Life Science Limited's Board approved an additional Working Capital Term Loan of ₹7.96 crore from HDFC Bank under ECLGS 5.0 on June 03, 2026. The meeting, held at the registered office, was conducted from 05:00 PM to 06:00 PM. The filing was made in compliance with SEBI regulations to ensure adequate working capital.

Crop Life Science reports FY26 net profit of ₹698.69 lakh

Crop Life Science Limited reported a net profit of ₹698.69 lakh for FY26, up from ₹662.03 lakh in the previous year, with revenue rising to ₹20,717.42 lakh. The Board approved the audited financial results on May 26, 2026, receiving an unmodified opinion from statutory auditors. Consolidated net profit increased to ₹649.49 lakh, while total assets grew to ₹20,531.69 lakh.

CLSL seeks vote to regularize director Sheetalben Shah

Crop Life Science Limited has announced a postal ballot notice to seek shareholder approval for the regularization of Ms. Sheetalben Rachit Shah as a Non-Executive Independent Director. The board meeting held on May 20, 2026, authorized the process, appointing Mr. Ranjit Kumar Singh as the Scrutinizer. The e-voting period is scheduled from May 26, 2026, to June 24, 2026, with results to be declared by June 26, 2026.